Paulina Hill
InvestorPartner at Sanofi Ventures · Board director at Avilar Therapeutics · Board director at NextPoint Therapeutics
Cambridge, Massachusetts, United States
About
Paulina Hill combines institutional VC and angel investing—writing $100K–$250K biotech checks to access scientific founders early; a PhD molecular biologist who actively architects complex therapeutics like targeted protein degraders.
Invests in
AI & Machine LearningBiotechData & InfrastructureHealthtechMedical Devices
Board director at Avilar Therapeutics
Intro paths
→
In turn, Paulina can intro founders to Avilar Therapeutics's investors below.
Board director at NextPoint Therapeutics
Intro paths
→
In turn, Paulina can intro founders to NextPoint Therapeutics's investors below.
NextPoint Therapeutics's investors · 7
Co-founders at NextPoint Therapeutics
GF
Gordon FreemanScientific Founder
XZ
XingXing ZangScientific Founder
Experience
- Windward BioBoard Observercurrent2026 — present
- Diagonal TherapeuticsBoard Membercurrent2026 — present
- NormunityBoard Observercurrent2025 — present
- NormunityBoard Member2022 — 2025
- Odyssey TherapeuticsBoard Membercurrent2025 — present
- Attovia TherapeuticsBoard Observercurrent2025 — present
- Nuvig Therapeutics Inc.Board Membercurrent2024 — present
- Tisento TherapeuticsBoard Membercurrent2023 — present
- Zag BioBoard Observercurrent2023 — present
- Avilar TherapeuticsBoard Membercurrent2023 — present
- NextPoint Therapeutics, Inc.Board Membercurrent2023 — present
- SanofiPartner at Sanofi Venturescurrent2022 — presentCambridge, Massachusetts, United States
- Omega FundsPrincipal2019 — 2021Greater Boston
- Scorpion TherapeuticsBoard Observer2020 — 2021Boston, Massachusetts, United States
- IFM TherapeuticsBoard Member2019 — 2021
- Arrakis TherapeuticsBoard Observer2019 — 2021
- Polaris PartnersHealthcare Investment Team2012 — 2018Greater Boston
- MITResearch Affiliate in Langer Lab, Department of Chemical Engineering2012 — 2014
- Startup Leadership ProgramFellow and Co-Program Leader2011 — 2012
- MIT Langer LabPostdoctoral Research Fellow2009 — 2012
- MIT Postdoctoral AssociationFounding President2009 — 2012
- Siemens Venture CapitalMarket Analysis Intern2010 — 2011
- Wake Forest Institute for Regenerative MedicineTissue Engineering Pre-Doctoral Fellow2004 — 2009
- Office of Technology Asset Management, Wake Forest University Health SciencesTechnology Transfer Intern2008
- East Carolina University Brody School of MedicineUndergraduate Research Assistant2002 — 2004
Skills & more
Lifesciences14Biotechnology18Cell Culture13Molecular Biology11Biomaterials8Technology Transfer28Biochemistry48Biomedical Engineering8Nanotechnology4Drug Delivery8Chemistry13Protein Purification3
+9 more
EntrepreneurshipScienceTissue EngineeringHPLCStart-upsCellPatentsELISANeuroscienceLanguages Polish
From Paulina's professional profile.
Colleagues at Sanofi Ventures
Anne
Investor at Sanofi Ventures
Becca
Investor at Sanofi Ventures
Camille Ridel
Investor at Sanofi Ventures
Chris
Investor at Sanofi Ventures
Christopher Gagliardi
Principal at Sanofi Ventures
Cris De Luca
Partner, Digital at Sanofi Ventures
Francesc Dosrius Lleonart
Associate Director of Investments at Sanofi Ventures
Jason P. Hafler
Managing Director at Sanofi Ventures
Frequently asked questions
- Who is Paulina Hill?
- Paulina Hill combines institutional VC and angel investing—writing $100K–$250K biotech checks to access scientific founders early; a PhD molecular biologist who actively architects complex therapeutics like targeted protein degraders.
- Where does Paulina Hill work?
- Paulina Hill is Partner at Sanofi Ventures and Board director at Avilar Therapeutics and Board director at NextPoint Therapeutics.
- What does Paulina Hill invest in?
- Paulina Hill invests in AI & Machine Learning, Biotech, Data & Infrastructure, Healthtech, Medical Devices.
- Where did Paulina Hill go to school?
- Paulina Hill studied at Massachusetts Institute of Technology (Postdoctoral Fellowship in Robert Langer's lab, Chemical Engineering); Wake Forest University School of Medicine (PhD, Molecular Medicine); East Carolina University (BS/BA, Quadruple major in Biochemistry).
Same school
Also attended Massachusetts Institute of Technology1,387
Fred WilsonCo-founder & Partner at Union Square VenturesElad GilSolo general partner investing through Gil CapitalAileen LeeFounder & Managing Partner of Cowboy VenturesHemant TanejaCEO & Managing Director of General CatalystNat FriedmanCo-lead of Meta Superintelligence Labs; co-founder of NFDGBrad FeldCo-founder of Foundry and Techstars
+ 1,381 more
Also attended Wake Forest University School of Medicine1
Also attended East Carolina University7
Ashley ValentineChief People Officer at GreycroftMelanie NessController at PROOFMichael HodgesSenior Advisor at Adjuvant CapitalJeff RinehartPartner at City LightRyan RossManaging Director at NaviMed CapitalMichele McElhinneyOperations Manager at Radian Capital
+ 1 more
Shared employers
Also worked at Windward Bio1
Also worked at Sanofi95
Walter OlesiakOperating Partner at Remiges Ventures, Inc.Christine AylwardFounder & Managing Partner at Magnetic VenturesAlan WaltsVenture Partner at Advent Life SciencesSun AltbachSenior Scientific Advisor at BOLD LongevityMatt VineSenior Associate at RRE VenturesWalter OlesiakOperating Partner at RDiscovery
)
+ 89 more
Also worked at Arrakis Therapeutics6
Also worked at Polaris Partners32
Dylan PearcePartner at GreycroftGraham BrownManaging Partner at Lerer HippeauMichael GreeleyCo-Founder and General Partner at Flare Capital PartnersSimeon SimeonovAdvisor at One Way VenturesDave BarrettSenior Advisory Partner at Polaris PartnersAlexandra CantleyManaging Partner at Polaris Partners
+ 26 more